| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14b02369b953bf4ebd31190c8cb63473 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate |
1992-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d3f3b6802b07ef63ea0377ab4bd6029
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57dfe491ac0879ab0cdacdf3ecc968f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_582eeed24d723a2d1e38669340e1524b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e0bef7346ee68ca117dbd53fd09a97a |
| publicationDate |
1994-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H0641122-A |
| titleOfInvention |
Novel quinoxaline derivative |
| abstract |
(57) [Summary] [Structure] General Formula (I) (In the formula, R represents a lower alkyl group.) A quinoxaline derivative or a pharmaceutically acceptable salt thereof. [Effect] The above quinoxaline derivative has an angiotensin II receptor antagonistic action and is useful as a therapeutic drug for hypertension. |
| priorityDate |
1992-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |